India 'privately' against patent-overriding drug permits
Indian government has "privately reassured" industry lobby group US-India Business Council that the country would not invoke 'compulsory licensing' for commercial purposes that could allow local drugmakers to make cheaper products by overriding patents of big global players.
Mar 09, 2016, 09:22 AM IST
Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies
Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the firm to launch copies of two drugs including AstraZeneca Plc`s heartburn pill Nexium, court documents showed.
Nov 18, 2014, 15:35 PM IST
36 more drugs to be cheaper as govt caps prices
The medicines join the 348 drugs deemed essential and that are therefore subject to price caps.
Sep 19, 2014, 16:23 PM IST
More medicines to be cheaper as govt planning to extend essential drugs list
Making more drugs subject to price caps will draw the ire of global drugmakers like Pfizer Inc, GlaxoSmithKline Plc and Abbott Laboratories.
Jun 24, 2014, 11:12 AM IST
